Pitcairn CO Grifols Sa Transaction History

Pitcairn CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$17.44 - $21.53 $475,832 - $587,424	-27,284 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$19.97 - $21.96 $20,349 - $22,377	-1,019 Reduced 3.6%	27,284 $583,000
Q2 2018 Aug 02, 2018	BUY	$20.16 - $24.68 $202,910 - $248,404	10,065 Added 55.19%	28,303 $609,000
Q1 2018 May 11, 2018	BUY	$20.31 - $24.95 $169,080 - $207,708	8,325 Added 83.98%	18,238 $387,000
Q4 2017 Feb 13, 2018	BUY	$20.99 - $23.89 $208,073 - $236,821	9,913	9,913 $228,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.